Decellularization and recellularization of cornea: Progress towards a donor alternative

• Published in: Methods (San Diego, Calif.) Calif.), 2020-01, Vol.171, p.86-96
• Main Authors: Fernández-Pérez, Julia, Ahearne, Mark
• Format: Article
• Language: English
• Subjects: Animals; Bioengineering - methods; Cornea; Cornea - growth & development; Cornea - pathology; Decellularization; Extracellular Matrix - chemistry; Extracellular Matrix - transplantation; Eye; Humans; Keratoplasty; Models, Animal; Tissue Donors; Tissue engineering; Tissue Engineering - trends; Tissue Scaffolds - chemistry
• ISSN: 1046-2023; 1095-9130
• DOI: 10.1016/j.ymeth.2019.05.009

•Different physical and chemical treatments can remove cells and cell components.•Scaffolds have been recellularized using stem cells or corneal derived cells.•Decellularized corneal scaffolds have been successfully transplanted into patients. The global shortage of donor corneas for transplantation has led to corneal bioengineering being investigated as a method to generate transplantable tissues. Decellularized corneas are among the most promising materials for engineering corneal tissue since they replicate the complex structure and composition of real corneas. Decellularization is a process that aims to remove cells from organs or tissues resulting in a cell-free scaffold consisting of the tissues extracellular matrix. Here different decellularization techniques are described, including physical, chemical and biological methods. Analytical techniques to confirm decellularization efficiency are also discussed. Different cell sources for the recellularization of the three layers of the cornea, recellularization methods used in the literature and techniques used to assess the outcome of the implantation of such scaffolds are examined. Studies involving the application of decellularized corneas in animal models and human clinical studies are discussed. Finally, challenges for this technology are explored involving scalability, automatization and regulatory affairs.